Published in Am J Cardiol on October 01, 1990
Analysis of hydroxylated metabolites of PCBs (OH-PCBs) and other chlorinated phenolic compounds in whole blood from Canadian inuit. Environ Health Perspect (2000) 1.48
Time trends of persistent organic pollutants and heavy metals in umbilical cord blood of Inuit infants born in Nunavik (Québec, Canada) between 1994 and 2001. Environ Health Perspect (2003) 1.03
Temporal trends of organochlorine concentrations in umbilical cord blood of newborns from the lower north shore of the St. Lawrence river (Québec, Canada). Environ Health Perspect (2002) 0.92
Establishment of a seafood index to assess the seafood consumption in pregnant women. Food Nutr Res (2013) 0.82
Meta-Analysis of Long-Chain Omega-3 Polyunsaturated Fatty Acids (LCω-3PUFA) and Prostate Cancer. Nutr Cancer (2015) 0.81
Fish oil significantly alters fatty acid profiles in various lipid fractions but not atherogenesis in apo E-KO mice. Eur J Nutr (2007) 0.79
Contribution of diet and major depression to incidence of acute myocardial infarction (AMI). Lipids Health Dis (2010) 0.78
A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med (1997) 19.93
A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med (1991) 6.13
Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr (1999) 5.12
A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA (1996) 3.69
Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med (2001) 3.56
Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. Circulation (1999) 3.26
Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation (1998) 3.19
Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Clin Nutr (2001) 3.12
Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation (2001) 2.80
Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation (2005) 2.77
Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med (1991) 2.68
Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst (1994) 2.68
Comparison of measures of fatty acid intake by subcutaneous fat aspirate, food frequency questionnaire, and diet records in a free-living population of US men. Am J Epidemiol (1992) 2.68
Comparison of the effects of oat bran and low-fiber wheat on serum lipoprotein levels and blood pressure. N Engl J Med (1990) 2.37
The influence of anxiety and depression on outcomes of patients with coronary artery disease. Arch Intern Med (2000) 2.34
Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res (1999) 2.30
Randomised trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet (1989) 2.28
The relation between dietary intake and adipose tissue composition of selected fatty acids in US women. Am J Clin Nutr (1998) 2.24
Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial. Ann Intern Med (1998) 2.22
Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation (1986) 2.22
Cost-effectiveness of a smoking cessation program after myocardial infarction. J Am Coll Cardiol (1993) 2.18
Fatty acid composition of the subcutaneous adipose tissue and risk of proliferative benign breast disease and breast cancer. J Natl Cancer Inst (1993) 2.15
Selection of patients for coronary angiography and coronary revascularization early after myocardial infarction: is there evidence for a gender bias? Ann Intern Med (1992) 2.11
Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group. Ann Intern Med (1996) 2.03
Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction. N Engl J Med (1992) 1.92
Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women. J Clin Endocrinol Metab (1997) 1.88
Cardiovascular disease in women. Circulation (1993) 1.87
Role of superficial femoral artery puncture in the development of pseudoaneurysm and arteriovenous fistula complicating percutaneous transfemoral cardiac catheterization. Cathet Cardiovasc Diagn (1992) 1.82
The use of nicotine-replacement therapy by hospitalized smokers. Am J Prev Med (1999) 1.78
Fatty acid composition of subcutaneous adipose tissue and diet in postmenopausal US women. Am J Clin Nutr (1991) 1.78
Low-density lipoprotein size, pravastatin treatment, and coronary events. JAMA (2001) 1.75
A prospective study of egg consumption and risk of cardiovascular disease in men and women. JAMA (1999) 1.74
Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial. J Am Coll Cardiol (1998) 1.67
Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse. Circulation (1998) 1.64
Plasma lipids and lipoproteins in vegetarians and controls. N Engl J Med (1975) 1.59
Effect of transport conditions on the stability of biochemical markers in blood. Clin Chem (1989) 1.58
Chewing the fat--how much and what kind? N Engl J Med (1991) 1.57
Beta-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma. Cancer (1999) 1.50
Significance of nitroglycerin-induced hypotension with inferior wall acute myocardial infarction. Am J Cardiol (1989) 1.44
High-density lipoprotein subfractions. Am J Med (1993) 1.42
Variations in cholesterol management practices of U.S. physicians. J Am Coll Cardiol (1997) 1.42
Problems on the pathway from risk assessment to risk reduction. Circulation (1998) 1.41
Effects of serum lipid levels on restenosis after coronary angioplasty. Am J Cardiol (1991) 1.41
The DASH Diet, Sodium Intake and Blood Pressure Trial (DASH-sodium): rationale and design. DASH-Sodium Collaborative Research Group. J Am Diet Assoc (1999) 1.40
Blood pressure in vegetarians. Am J Epidemiol (1974) 1.40
The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial. Am J Hypertens (2000) 1.39
Is there anything to add to our lipid risk factors for coronary heart disease? Am J Cardiol (1995) 1.39
Dietary fiber and cardiovascular disease--direct protection or indicator of a healthy lifestyle? Am J Prev Med (1993) 1.38
Relation of vessel wall shear stress to atherosclerosis progression in human coronary arteries. Arterioscler Thromb (1993) 1.38
Efficacy of a smoking cessation program for hospital patients. Arch Intern Med (1998) 1.28
Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia. Int J Clin Pract (2008) 1.27
Chest pain with angiographically insignificant coronary arterial obstruction. Clinical presentation and long-term follow-up. Am J Med (1980) 1.23
Smoking by patients in a smoke-free hospital: prevalence, predictors, and implications. Prev Med (2000) 1.23
AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol (2001) 1.17
Effect of dietary patterns on ambulatory blood pressure : results from the Dietary Approaches to Stop Hypertension (DASH) Trial. DASH Collaborative Research Group. Hypertension (1999) 1.14
Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: medical office assessment: Writing Group I. Circulation (2000) 1.13
Ingestion of egg raises plasma low density lipoproteins in free-living subjects. Lancet (1984) 1.12
Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia. J Lipid Res (2001) 1.11
Dietary Approaches to Stop Hypertension: rationale, design, and methods. DASH Collaborative Research Group. J Am Diet Assoc (1999) 1.11
Transluminal angioplasty: correlation of morphologic and angiographic findings in an experimental model. Circulation (1980) 1.09
A prospective study of nutritional factors and hypertension among US women. Circulation (1989) 1.08
Scanning electron microscopy after coronary transluminal angioplasty of normal canine coronary arteries. Am J Cardiol (1980) 1.07
Use of transoesophageal echocardiography to detect left atrial thrombi before percutaneous balloon dilatation of the mitral valve: a prospective study. Br Heart J (1992) 1.05
Transluminal coronary angioplasty of postmortem human hearts. Am J Cardiol (1981) 1.05
The association of dietary fat with serum cholesterol in vegetarians: the effect of dietary assessment on the correlation coefficient. Am J Epidemiol (1988) 1.03
Cigarette smoking and coronary heart disease: risks and management. Cardiol Clin (1996) 1.02
Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study. J Hypertens (2001) 1.00
Controlled trial of fish oil for regression of human coronary atherosclerosis. HARP Research Group. J Am Coll Cardiol (1995) 1.00
Relation of moderate alcohol consumption and risk of systemic hypertension in women. Am J Cardiol (1990) 0.99
Implications of the ACCORD lipid study: perspective from the Residual Risk Reduction Initiative (R(3)i). Curr Med Res Opin (2010) 0.97
Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism. J Lipid Res (1994) 0.97
Effects of estrogenic oral contraceptives on the lipoprotein B particle system defined by apolipoproteins E and C-III content. J Lipid Res (1999) 0.96
Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations. Cholesterol and Recurrent Events CARE Investigators. J Am Coll Cardiol (1999) 0.96
Coagulation activation following estrogen administration to postmenopausal women. Thromb Haemost (1992) 0.96
Cost-effectiveness of pravastatin therapy for survivors of myocardial infarction with average cholesterol levels. Am Heart J (2001) 0.96
Lipid-lowering therapy in acute coronary syndromes. JAMA (2001) 0.94
A prospective study of plasma fish oil levels and incidence of myocardial infarction in U.S. male physicians. J Am Coll Cardiol (1995) 0.91
Clinical angiographic regression of atherosclerosis after partial ileal bypass. Atherosclerosis (1983) 0.91
Endothelial cell damage and thrombosis following partial coronary arterial constriction: relevance to the pathogenesis of myocardial infarction. Isr J Med Sci (1978) 0.91
The effect of potassium supplementation in persons with a high-normal blood pressure. Results from phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol (1995) 0.90
More on chewing the fat. The good fat and the good cholesterol. N Engl J Med (1991) 0.90
Quantitative angiographic and statistical methods to assess serial changes in coronary luminal diameter and implications for atherosclerosis regression trials. Am J Cardiol (1992) 0.89
Effect of ingestion of meat on plasma cholesterol of vegetarians. JAMA (1981) 0.89
Differential metabolism of human VLDL according to content of ApoE and ApoC-III. Arterioscler Thromb Vasc Biol (2001) 0.89
Cholesterol and Recurrent Events: a secondary prevention trial for normolipidemic patients. CARE Investigators. Am J Cardiol (1995) 0.89
Effect of linoleic and oleic acids on blood pressure, blood viscosity, and erythrocyte cation transport. J Am Coll Nutr (1987) 0.88
Effects of a low-fat diet on plasma lipoprotein levels. Arch Intern Med (1986) 0.88
The platelet Pl(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction. Am J Cardiol (2001) 0.87
Echocardiographic diagnosis of large fungal verruca attached to mitral valve. Br Heart J (1976) 0.87
Lack of an effect of dietary saturated fat and cholesterol on blood pressure in normotensives. Hypertension (1984) 0.87
The potential role of viruses in the pathogenesis of atherosclerosis. Circulation (1988) 0.87
Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism. J Clin Invest (1993) 0.86
Plasma lipoprotein levels in vegetarians. The effect of ingestion of fats from dairy products. JAMA (1985) 0.86